Cyclins and cyclin‐dependent kinases (CDKs) are frequently dysregulated in human cancers and represent compelling therapeutic targets. Beyond their well‐recognized roles in cell cycle control, CDK/cyclin complexes orchestrate diverse oncogenic processes, including transcription, genome maintenance, epigenetics, metabol...
Suya Zheng, Zhi-Peng Shen, Yuan-Fang Wu et al.· MedComm· 0 citations
MDM2 is an oncogenic E3 ubiquitin ligase best known for targeting the tumor suppressor p53 and is frequently amplified in human cancers, including dedifferentiated liposarcoma (DDLPS). We show that supraphysiological MDM2 expression can be exploited to reprogram its ligase activity toward selective degradation of o...
Ye Chen, Long Xie, Xian Guan et al.· Cell Death & Disease· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.